1.
van de Sande M, Tap WD, Gelhorn HL, Ye X, Speck RM, Palmerini E, et al. Pexidartinib improves physical functioning and stiffness in patients with tenosynovial giant cell tumor: results from the ENLIVEN randomized clinical trial. ActaO [Internet]. 2021 May 12 [cited 2024 Nov. 3];92(4):493-9. Available from: https://actaorthop.org/actao/article/view/1190